Prevention of interferon-stimulated gene expression using microRNA-designed hairpins
Tóm tắt
Từ khóa
Tài liệu tham khảo
Raoul C, Abbas-Terki T, Bensadoun JC, Guillot S, Haase G, Szulc J et al. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med 2005; 11: 423–428.
Zimprich A, Biskup S, Leitner P, Farrer M, Lincoln S, Kachergus J et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004; 44: 601–607.
Brummelkamp TR, Bernards R, Agami R . A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550–553.
Alvarez VA, Ridenour DA, Sabatini BL . Retraction of synapses and dendritic spines induced by off-target effects of RNA interference. J Neurosci 2006; 26: 7820–7825.
Cao W, Hunter R, Strnatka D, Mcqueen CA, Erickson RP . DNA constructs designed to produce short hairpin, interfering RNAs in transgenic mice sometimes show early lethality and an interferon response. J Appl Genet 2005; 46: 217–225.
Kariko K, Bhuyan P, Capodici J, Weissman D . Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through Toll-like receptor 3. J Immunol 2004; 172: 6545–6549.
Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 2005; 11: 263–270.
Sledz CA, Holko M, De Veer MJ, Silverman RH, Williams BR . Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 2003; 5: 834–839.
Pebernard S, Iggo RD . Determinants of interferon-stimulated gene induction by RNAi vectors. Differentiation 2004; 72: 103–111.
Garcia-Sastre A, Biron CA . Type 1 Interferons and the virus–host relationship: a lesson in détente. Science 2006; 312: 879–882.
Boden D, Pusch O, Silbermann R, Lee F, Tucker L, Ramratnam B . Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res 2004; 32: 1154–1158.
Zeng Y, Wagner EJ, Cullen BR . Both natural and designed microRNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell 2002; 9: 1327–1333.
Cullen BR . Induction of stable RNA interference in mammalian cells. Gene Therapy 2006; 13: 503–508.
Gloeckner CJ, Kinkl N, Schumacher A, Braun RJ, O'Neill E, Meitinger T et al. The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum Mol Genet 2006; 15: 223–232.
Wiznerowicz M, Trono D . Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003; 77: 8957–8961.
Bauer M, Szulc J, Meyer M, Jensen CH, Abbas Terki T, Meixner A et al. Delta-like 1 participates in the specification of ventral midbrain progenitor-derived dopaminergic neurons. J Neurochem 2008; 104: 1101–1115.
MacLeod D, Dowman J, Hammond R, Leete T, Inoue K, Abeliovich A . The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 2006; 52: 587–593.
Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, Iggo R . Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 2003; 34: 263–264.
Karpala AJ, Doran TJ, Bean AG . Immune responses to dsRNA: implications for gene silencing technologies. Immunol Cell Biol 2005; 83: 211–216.
Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T . Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853–858.
Manche L, Green SR, Schmedt C, Mathews MB . Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol Cell Biol 1992; 12: 5238–5248.
McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I et al. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci USA 2008; 105: 5868–5873.